| dbo:abstract
|
- COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. On 17 February 2021, South Africa started its national vaccination program against COVID-19. The program will go through in phases, prioritizing healthcare and frontline workers and then those over the age of 60. According to health officials, South Africa has administered 31,439,128 vaccine doses across the country as of 28 February 2022. South Africa has accepted delivery of 3 different vaccines, Janssen (Johnson & Johnson), Pfizer-BioNTech and Oxford-AstraZeneca, administering both Janssen and Pfizer-BioNTech, with the Oxford-AstraZeneca vaccine suspended, after a small study cast doubt on its effectiveness against the Beta variant. (en)
|
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 159518 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:budget
|
- TBA (en)
- R1.25 billion (en)
- R10 billion (en)
- R2.2 billion (en)
- USD $1,000,000,000 (en)
|
| dbp:caption
|
- 0001-07-20 (xsd:gMonthDay)
- Vaccines administered per pharmaceutical company as of 27 Jul 2021 (en)
|
| dbp:cause
| |
| dbp:color
|
- #32CD32 (en)
- #DC143C (en)
- #fffb00 (en)
|
| dbp:date
|
- 0001-02-17 (xsd:gMonthDay)
|
| dbp:event
|
- COVID-19 vaccination in South Africa (en)
|
| dbp:footer
|
- Vaccination Sites in South Africa (en)
|
| dbp:image
|
- Charlotte.Maxeke. Joburg.Hospital.JPG (en)
- Kbh.jpg (en)
- The Chris Hani Baragwanath Hospital, Soweto.jpg (en)
- Tygerberg from air.jpg (en)
|
| dbp:label
|
- Janssen (en)
- Oxford–AstraZeneca (en)
- Pfizer–BioNTech (en)
|
| dbp:location
| |
| dbp:nativeName
| |
| dbp:organisers
| |
| dbp:outcome
|
- * of the South African adult population with at least 1 dose (en)
|
| dbp:participants
|
- 7720551 (xsd:integer)
- 21305519 (xsd:integer)
- 23718577 (xsd:integer)
- * 13,584,968 people with only 1 dose of Pfizer–BioNTech
* 10,054,859 people with 2 doses of Pfizer–BioNTech
* 518,134 people with a booster dose of Pfizer–BioNTech (en)
|
| dbp:ref
| |
| dbp:timezone
| |
| dbp:title
|
- COVID-19 vaccination in South African (en)
|
| dbp:value
|
- 0 (xsd:integer)
- 22.130000 (xsd:double)
- 77.870000 (xsd:double)
|
| dbp:venue
| |
| dbp:website
| |
| dbp:width
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. (en)
|
| rdfs:label
|
- COVID-19 vaccination in South Africa (en)
|
| rdfs:seeAlso
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
